North America Leukapheresis Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Product Type (Leukapheresis Devices and Leukapheresis Disposables), Application (Research Applications and Therapeutic Applications), and End User (Blood Component Providers and Blood Centers, Academic and Research Institutes, Pharmaceutical and Biotechnology Companies, and Hospitals and Transfusion Centers)
Market Introduction
The North American Leukapheresis market is analyzed based on three large countries: the United States, Canada, and Mexico. The US region is contributing a major share in the growth of leukapheresis market. According to the 2017 United Nations Aging Report, there were 962 million people around the world who were 60 years of age or older, and the number is expected to reach nearly 2.1 billion by 2050. The number of Americans aged 65 and over is projected to more than double from 46 million in 2016 to over 98 million in 2060. The proportion of the world population aged 65 and over is expected to increase by 15 percent. Hyperleukocytosis in AML with leukostasis is a serious life-threatening disease with high early mortality and requires immediate cytoreductive therapy. The American Society of Apheresis currently recommends therapeutic leukapheresis in patients with a white blood cell count> 100 G / L with signs of leukostasis. The Transfusion Medical Service will perform apheresis in most United States medical centers where this therapeutic modality is available. Strict rules govern how the procedures are carried out and who is allowed to carry them out (i.e., level of training and supervision). Therefore, the blood bank is appropriate for the entire harvesting process of the peripheral blood stem, as it is basically a variant of leukapheresis. In addition, since the product's processing and storage usually take place in the blood bank, the entire process is kept under the supervision of one unit, which makes quality control considerably easier. According to the American Cancer Society, 60,530 new cases of all types of leukemia were diagnosed in 2020, with 23,100 deaths recorded. Acute myeloid leukemia is the most common in the US, with 19,940 cases. In addition, research and development and new technological advances are other factors driving the market growth.
North America has been witnessing a growing number of COVID-19 cases since its outbreak. The cases are also increasing in Mexico. In Mexico. At present, the majority of the diagnostic laboratories and research institutes are engaged in diagnosing the COVID-19 patients. Currently, the COVID-19 diagnostic testing industry is witnessing upsurge on account of a growing number of cases coupled with the increasing emergency use authorizations from the regulatory bodies. In addition, With the WHO declaring the COVID-19 outbreak a pandemic, a mix of established pharmaceutical and biopharmaceutical companies and small startups have stepped forward to develop treatments that target the infection. The U.S. Food and Drug Administration issued an emergency use authorization for a blood purification system to treat patients 18 years of age or older with confirmed Coronavirus Disease 2019 (COVID-19) admitted to the intensive care unit (ICU) with confirmed or imminent respiratory failure. The FDA issued this emergency use authorization to Terumo BCT Inc. and Marker Therapeutics AG for their Spectra Optia Apheresis System and Depuro D2000 Adsorption Cartridge devices.
Get more information on this report :
Market Overview and Dynamics
The leukapheresis market in North America is expected to grow from US$ 28.54 million in 2021 to US$ 52.65 million by 2028; it is estimated to grow at a CAGR of 9.1% from 2021 to 2028. The incidence of blood-related disorders is rising in developing countries due to the shift in lifestyle owing to the adoption of modern facilities. The modernization of facilities has led to reduction in physical activities of people, unlike stress levels, which are increasing due to various professional and personal factors. Developing countries are significantly focusing on the advancement of their healthcare facilities. For example, Hemophilia Federation (HFI) is a nonprofit organization that has worked closely with the World Federation of Hemophilia (WFH) to spread awareness and educate people regarding affordable treatments available for hemophilia, thereby improving diagnosis and therapy. Thus, the abovementioned factors are providing opportunities for the growth of the leukapheresis market.
Key Market Segments
In terms of product type, the leukapheresis disposables segment held a larger share in 2021. Based on application, research applications segment held the largest share in 2021. Based on end user, blood component providers and blood centers segment held the largest share in 2021.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the leukapheresis market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Asahi Kasei Corporation; Fresenius SE & Co. KGaA; Haemonetics Corporation; Terumo Corporation; STEMCELL Technologies Inc.; HemaCare; Macopharma; AllCells; STEMEXPRESS; and BioIVT among others.
Reasons to buy report
- To understand the North America leukapheresis market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America leukapheresis market
- Efficiently plan M&A and partnership deals in North America leukapheresis market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America leukapheresis market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
North America Leukapheresis Market Segmentation
North America Leukapheresis Market – By Product Type
- Leukapheresis Disposables
- Leukapheresis Devices
North America Leukapheresis Market – By Application
- Research Applications
- Therapeutic Applications
North America Leukapheresis Market – By Product Type
- Blood Component Providers and Blood Centers
- Hospitals and Transfusion Centers
- Pharmaceutical and Biotechnology Companies
- Academic and Research Institutes
North America Leukapheresis Market – By Country
- US
- Canada
- Mexico
North America Leukapheresis Market – Companies Mentioned
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Leukapheresis Market – By Product Type
1.3.2 North America Leukapheresis Market – By Application
1.3.3 North America Leukapheresis Market – By End User
1.3.4 North America Leukapheresis Market – By Country
2. North America Leukapheresis Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Leukapheresis Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.3 Expert Opinions
5. North America Leukapheresis Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Surging Number of Voluntary Blood Donors
5.1.2 Raising Incidence of Hematologic Diseases
5.1.3 Up-lifting Elderly Population
5.2 Key Market Restraints
5.2.1 High Price of Leukapheresis
5.3 Key Market Opportunities
5.3.1 Growing Opportunities in Emerging Economies
5.4 Future Trends
5.4.1 Progress in Therapeutic Apheresis
5.5 Impact Analysis
6. North America Leukapheresis – Market Analysis
6.1 North America Leukapheresis Market Revenue Forecast and Analysis
7. North America Leukapheresis Market Analysis – by Product Type
7.1 Overview
7.2 North America Leukapheresis Market Share by Product Type 2021 & 2028 (%)
7.3 Leukapheresis Devices
7.3.1 Overview
7.3.2 Leukapheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.1 Apheresis Devices
7.3.2.1.1 Overview
7.3.2.1.2 Apheresis Devices Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.2 Leukapheresis ColuMillions and Cell Separators
7.3.2.2.1 Overview
7.3.2.2.2 Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecast to 2028 (US$ Million)
7.3.2.3 Leukoreduction Filters
7.3.2.3.1 Overview
7.3.2.3.2 Leukoreduction Filters Market Revenue and Forecast to 2028 (US$ Million)
7.4 Leukapheresis Disposables
7.4.1 Overview
7.4.2 Leukapheresis Disposables Market Revenue and Forecast to 2028 (US$ Million)
8. North America Leukapheresis Market Analysis – by Application
8.1 Overview
8.2 North America Leukapheresis Market Share by Application 2021 & 2028 (%)
8.3 Research Applications
8.3.1 Overview
8.3.2 Research Applications Market Revenue and Forecast to 2028 (US$ Million)
8.4 Therapeutic Applications
8.4.1 Overview
8.4.2 Therapeutic Applications Market Revenue and Forecast to 2028 (US$ Million)
9. North America Leukapheresis Market Analysis – by End User
9.1 Overview
9.2 North America Leukapheresis Market Share by End User 2021 & 2028 (%)
9.3 Pharmaceutical and Biotechnology Companies
9.3.1 Overview
9.3.2 Pharmaceutical and Biotechnology Companies Market Revenue and Forecast to 2028 (US$ Million)
9.4 Blood Component Providers and Blood Centers
9.4.1 Overview
9.4.2 Blood Component Providers and Blood Centers Market Revenue and Forecast to 2028 (US$ Million)
9.5 Academic and Research Institutes
9.5.1 Overview
9.5.2 Academic and Research Institutes Market Revenue and Forecast to 2028 (US$ Million)
9.6 Hospitals and Transfusion Centers
9.6.1 Overview
9.6.2 Hospitals and Transfusion Centers Market Revenue and Forecast to 2028 (US$ Million)
10. North American Leukapheresis Market – Country Analysis
10.1 Overview
10.1.1 North America: Leukapheresis Market, by Country, 2021 & 2028 (%)
10.1.1.1 US: Leukapheresis Market– Revenue and Forecast to 2028 (USD Million)
10.1.1.1.1 Overview
10.1.1.1.2 US: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.1.3 US: Leukapheresis Market, by Product type, 2019–2028 (USD Million)
10.1.1.1.3.1 US: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.1.4 US: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.1.5 US: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.2 Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.1 Overview
10.1.1.2.2 Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.2.3 Canada: Leukapheresis Market, by Product type, 2019–2028 (USD Million)
10.1.1.2.3.1 Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.2.4 Canada: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.2.5 Canada: Leukapheresis Market, by End User, 2019–2028 (USD Million)
10.1.1.3 Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.1 Overview
10.1.1.3.2 Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
10.1.1.3.3 Mexico: Leukapheresis Market, by Product type – 2019–2028 (USD Million)
10.1.1.3.3.1 Canada: Leukapheresis Market, by Leukapheresis Devices, 2019–2028 (USD Million)
10.1.1.3.4 Mexico: Leukapheresis Market, by Application, 2019–2028 (USD Million)
10.1.1.3.5 Mexico: Leukapheresis Market, by End User, 2019–2028 (USD Million)
11. North America Leukapheresis Market – Impact of COVID-19 Pandemic
11.1 Impact Assessment of COVID-19 Pandemic
12. Leukapheresis Market– Industry Landscape
12.1 Overview
12.2 Organic Developments
12.2.1 Overview
12.3 Inorganic Developments
12.3.1 Overview
13. Company Profiles
13.1 Asahi Kasei Corporation
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Fresenius SE & Co. KGaA
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 Haemonetics Corporation
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Terumo Corporation
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 STEMCELL Technologies Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 HemaCare
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Macopharma
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 AllCells
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 STEMEXPRESS
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
13.10 BioIVT
13.10.1 Key Facts
13.10.2 Business Description
13.10.3 Products and Services
13.10.4 Financial Overview
13.10.5 SWOT Analysis
13.10.6 Key Developments
14. Appendix
14.1 About the Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 2. US Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 3. US Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 4. US Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 8. Canada Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico Leukapheresis Market, by Product type – Revenue and Forecast to 2028 (USD Million)
Table 10. Mexico Leukapheresis Market, by Leukapheresis Devices – Revenue and Forecast to 2028 (USD Million)
Table 11. Mexico Leukapheresis Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 12. Mexico Leukapheresis Market, by End User – Revenue and Forecast to 2028 (USD Million)
Table 13. Organic Developments Done by Companies
Table 14. Inorganic Developments Done by Companies
Table 15. Glossary of Terms, Leukapheresis Market
LIST OF FIGURES
Figure 1. North America Leukapheresis Market Segmentation
Figure 2. North America Leukapheresis Market Segmentation, By country
Figure 3. North America Leukapheresis Market Overview
Figure 4. North America Leukapheresis Disposables Segment Held Largest Share of Leukapheresis Market
Figure 5. The US to Show Significant Growth During Forecast Period
Figure 6. North America Leukapheresis Market, Industry Landscape
Figure 7. North America PEST Analysis
Figure 8. North America Leukapheresis market impact analysis of driver and restraints
Figure 9. North America Leukapheresis Market – Revenue Forecast and Analysis (2021-2028)
Figure 10. North America Leukapheresis Market Share by Product Type 2021 & 2028 (%)
Figure 11. Leukapheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 12. Apheresis Devices Market Revenue and Forecasts to 2028 (US$ Million)
Figure 13. Leukapheresis ColuMillions and Cell Separators Market Revenue and Forecasts to 2028 (US$ Million)
Figure 14. Leukoreduction Filters Market Revenue and Forecasts to 2028 (US$ Million)
Figure 15. Leukapheresis Disposables Market Revenue and Forecasts to 2028 (US$ Million)
Figure 16. North America Leukapheresis Market Share by Application 2021 & 2028 (%)
Figure 17. Research Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 18. Therapeutic Applications Market Revenue and Forecasts to 2028 (US$ Million)
Figure 19. North America Leukapheresis Market Share by End User 2021 & 2028 (%)
Figure 20. Pharmaceutical and Biotechnology Companies Market Revenue and Forecasts to 2028 (US$ Million)
Figure 21. Blood Component Providers and Blood Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 22. Academic and Research Institutes Market Revenue and Forecasts to 2028 (US$ Million)
Figure 23. Hospitals and Transfusion Centers Market Revenue and Forecasts to 2028 (US$ Million)
Figure 24. North America: Leukapheresis Market, by Key Country – Revenue (2021 USD Million)
Figure 25. North America: Leukapheresis Market, by Country, 2021 & 2028 (%)
Figure 26. US: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 27. Canada: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 28. Mexico: Leukapheresis Market – Revenue and Forecast to 2028 (USD Million)
Figure 29. Impact of COVID-19 Pandemic in North American Country Markets
- Asahi Kasei Corporation
- Fresenius SE & Co. KGaA
- Haemonetics Corporation
- Terumo Corporation
- STEMCELL Technologies Inc.
- HemaCare
- Macopharma
- AllCells
- STEMEXPRESS
- BioIVT
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America leukapheresis market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America leukapheresis market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the leukapheresis market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution